このページは機械翻訳されています。他のページは英語で表示される場合があります。
View in English
AADNスコア: 肝臓細胞がん患者におけるトランス動脈化学栓塞,シンチリマブおよびレンバチニブに対する反応を予測する
- Xue Zhang 1, Min-Jun Liao 1,2, Li-Ying Ren 1, Wan-Ying Qin 3, Shao-Wei Mu 4, Shao-Ping She 1, Ran Fei 1, Xu Cong 1, Yuan-Ping Zhou 2, Dong-Bo Chen 1, Hong-Song Chen 1,5
- Xue Zhang 1, Min-Jun Liao 1,2, Li-Ying Ren 1
- 1Peking University People's Hospital, Peking University Hepatology Institute, Infectious Disease and Hepatology Center of Peking University People's Hospital, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis, Beijing 100044, China.
- 2Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong Province, China.
- 3Laboratory of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin 541000, Guangxi Zhuang Autonomous Region, China.
- 4Department of Hepatobiliary Surgery, Peking University People's Hospital, Beijing 100044, China.
- 5Peking University Third Hospital, Beijing 100191, China. chenhongsong2999@163.com.
- 0Peking University People's Hospital, Peking University Hepatology Institute, Infectious Disease and Hepatology Center of Peking University People's Hospital, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International Cooperation Base for Science and Technology on NAFLD Diagnosis, Beijing 100044, China.
関連する実験動画
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

